Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
AKRO
Stock Latest News
Ratings
Akero Therapeutics: Strong Financials and Promising Clinical Progress Justify Buy Rating
9d ago
AKRO
Premium
Ratings
Promising Developments and Strong Financial Position Support Buy Rating for Akero Therapeutics
9d ago
AKRO
Premium
The Fly
Akero Therapeutics price target raised to $75 from $72 at H.C. Wainwright
9d ago
AKRO
Premium
The Fly
Akero Therapeutics price target lowered to $90 from $96 at Morgan Stanley
10d ago
AKRO
Premium
Ratings
Akero Therapeutics: Buy Rating Backed by Groundbreaking Clinical Results and Strong Financial Position
10d ago
AKRO
Premium
Company Announcements
Akero Therapeutics Reports Promising Clinical Trial Results
11d ago
AKRO
Premium
Ratings
Akero Therapeutics: Strong Financial Health and Promising Clinical Trial Results Drive Buy Rating
11d ago
AKRO
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
12d ago
IPA
PBM
Premium
The Fly
Akero Therapeutics reports Q4 EPS (99c), consensus ($1.12)
12d ago
AKRO
Premium
The Fly
89bio initiated with an Outperform at Wolfe Research
1M ago
AKRO
ETNB
Premium
The Fly
89bio price target raised to $38 from $25 at UBS, says shares ‘undervalued’
1M ago
AKRO
ETNB
Premium
The Fly
Akero Therapeutics price target raised to $109 from $42 at UBS
1M ago
AKRO
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
AKRO
ALLK
Premium
The Fly
Akero upgraded to Buy at BofA after ‘transformative’ liver data
1M ago
AKRO
ETNB
Premium
The Fly
Akero Therapeutics upgraded to Buy from Neutral at BofA
1M ago
AKRO
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
AKRO
ALLK
Premium
The Fly
Akero Therapeutics 5.333M share Secondary priced at $48.00
1M ago
AKRO
Premium
The Fly
Akero Therapeutics price target raised to $96 from $46 at Morgan Stanley
1M ago
AKRO
Premium
The Fly
Akero Therapeutics price target raised to $73 from $56 at Canaccord
1M ago
AKRO
Premium
Market News
Akero Shares Skyrocket as MASH Drug Delivers Game-Changing Results
1M ago
LLY
AKRO
Premium
The Fly
Akero Therapeutics price target raised to $80 from $65 at Citi
1M ago
AKRO
Premium
The Fly
Akero Therapeutics announces $300M common stock offering
1M ago
AKRO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
